 |
|
Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
Thorsten Steiner, Martin Köhrmann, Peter D. Schellinger, Georgios Tsivgoulis
J Stroke. 2018;20(3):292-301. Published online 2018 Sep 30 DOI: https://doi.org/10.5853/jos.2018.02250
|
|
Citations to this article as recorded by
 Andexanet alfa for the reversal of factor Xa inhibitors
J Favresse, M Hardy, MA van Dievoet, AL Sennesael, J Douxfils, CM Samama, O Vornicu, AS Dincq, S Lessire, F Mullier
Expert Opinion on Biological Therapy.2019; 19(5): 387. CrossRef Patients on NOACs in the Emergency Room
Stefan T. Gerner, Hagen B. Huttner
Current Neurology and Neuroscience Reports.2019;[Epub] CrossRef Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
Joji B. Kuramatsu, Jochen A. Sembill, Hagen B. Huttner
Critical Care.2019;[Epub] CrossRef Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment
A. A. Kulesh, V. E. Drobakha, V. V. Shestakov
Neurology, Neuropsychiatry, Psychosomatics.2019; 11(3S): 4. CrossRef
|